TOBINintel · Condition

IBS & Gut Barrier Dysfunction

Symptoms are mapped across diet, motility, visceral sensitivity, microbial ecology, immune activation and exposures, while red flags are routed to conventional evaluation first.

Key points

  • Core Fifth Estate case: a stool organism report is classified as active infection, colonization, dysbiosis hypothesis, past exposure or incidental detection before any antimicrobial is discussed.
  • Test to discuss: Red-flag screen (bleeding, weight loss, anemia, onset over 50)
  • Test to discuss: Celiac serology and calprotectin
  • Test to discuss: Targeted stool studies only when justified
  • Test to discuss: Symptom and food diary
  • Regular meal timing and fiber titration
  • Stress and sleep management
  • Avoid unnecessary antibiotics

Root-cause chain

Post-infectious immune activation → Visceral hypersensitivityB

I · Observational association · Post-infectious IBS cohorts show persistent mucosal immune changes and altered sensation.

Fermentable carbohydrate load → Bloating and painA

N · Randomized evidence · Low-FODMAP trials demonstrate symptom reduction in a substantial subgroup.

Bacteriome and bile-acid alteration → Stool-form changeC

I · Mechanistic plausibility · Bile-acid malabsorption and microbial shifts plausibly affect transit; testing is often inconclusive.

Stress and autonomic load → Symptom amplificationB

B · Randomized evidence · Gut-directed hypnotherapy and CBT reduce symptom severity in trials.

Protocols by lane

Evidence grade + regulatory status
Conventional: Targeted pharmacotherapy by subtypeA

Guideline-based agents for IBS-C, IBS-D and pain-predominant subtypes.

Status: FDA-approved · Cautions: Subtype-specific contraindications; review before each change.

Functional: Dietitian-led low-FODMAP trial with structured reintroductionA

Effective in a defined subgroup when supervised.

Status: Lifestyle · Cautions: Avoid long-term restriction; nutrient adequacy and eating-disorder risk must be monitored.

Integrative: Gut-directed hypnotherapy or CBTA

Reduces symptom severity with durable effects.

Status: Lifestyle · Cautions: Requires trained practitioner.

Orthomolecular: Soluble fiber (psyllium) titrationB

Improves global symptoms, particularly in IBS-C.

Status: Supplement · Cautions: Start low; worsens bloating if escalated quickly.

Traditional: Enteric-coated peppermint oilB

Antispasmodic benefit in several trials.

Status: Supplement · Cautions: Reflux aggravation; avoid in significant GERD.

Energy / Physical: Abdominal massage or PEMFD

Minimal controlled evidence.

Status: Investigational · Cautions: Never a substitute for red-flag evaluation.

Monitoring

  • Symptom severity score monthly
  • Dietary adequacy review during restriction
  • Reintroduction schedule after low-FODMAP phase

Go deeper

iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.